ANF
Abercrombie & Fitch Co.
ANF has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
ANF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ANF's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ANF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.8x | $89.96 | -40% |
| Forward | 12x | $150 | — |
| Fair | 13x | $155 | +2.9% |
| Current | 13x | $150 | — |
| Expensive | 26x | $299 | +98% |
Historical ranges are pointers, not guarantees.
ANF's PE is in its fair range at 13x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ANF Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ANF, with profitability improving.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ANF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.43 | +7.2% |
| Q3 2026 | $11.60 | +10% |
| Q2 2026 | $10.34 | +2% |
| Q1 2026 | $10.46 | -2.2% |
| Q4 2025 | $10.41 | +3% |
| Q3 2025 | $10.55 | +12% |
| Q2 2025 | $10.14 | +26% |
| Q1 2025 | $10.69 | +72% |
| Q4 2024 | $10.11 | +153% |
ANF has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ANF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +4.8% |
| Q2 2026 | $1.1B | +1.5% |
| Q1 2026 | $1.7B | +5.4% |
| Q4 2025 | $1.3B | +6.8% |
| Q3 2025 | $1.2B | +6.6% |
| Q2 2025 | $1.1B | +7.5% |
| Q1 2025 | $1.6B | +9.1% |
| Q4 2024 | $1.2B | +14% |
ANF's revenue has grown year over year for 15 quarters in a row: $1.3B last quarter, up 4.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +2.8 points |
| Q2 2026 | 8% | -1.3 points |
| Q1 2026 | 14% | -2 points |
| Q4 2025 | 12% | -2.8 points |
| Q3 2025 | 17% | +1.6 points |
| Q2 2025 | 9.3% | -3.5 points |
| Q1 2025 | 16% | +0.8 points |
| Q4 2024 | 15% | +1.8 points |
ANF has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ANF on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ANF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $201.1M | +297% |
| Q2 2026 | -$17.1M | +$37.7M |
| Q1 2026 | $250.6M | -2.4% |
| Q4 2025 | $131.8M | +43% |
| Q3 2025 | $50.7M | -59% |
| Q2 2025 | -$54.8M | -198% |
| Q1 2025 | $256.8M | -6.3% |
| Q4 2024 | $92.2M | -2.9% |
ANF has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ANF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
ANF has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ANF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.7 | Neutral |
| Stochastic | 78.3 | Neutral |
ANF's weekly RSI is 65 (neutral) and its Stochastic is 78 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ANF PE vs Consumer Cyclical Sector
| Metric | ANF | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 18x | 28% below |
| PE % | 48 | 47 | 1 pt above |
ANF is trading at 13x earnings, a 28% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ANF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $148.5 | 1.4% above |
| 20 week MA | $128.5 | 17% above |
| 50 week MA | $108.1 | 39% above |
| 100 week MA | $100.3 | 50% above |
| 200 week MA | $96.1 | 57% above |
ANF has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ANF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.3 | $20.1 | +16% |
| 2021 | $20.1 | $34.4 | +71% |
| 2022 | $34.4 | $22.3 | -35% |
| 2023 | $22.3 | $88.2 | +296% |
| 2024 | $88.2 | $153.9 | +74% |
| 2025 | $153.9 | $126.8 | -18% |
| 2026 YTD | $126.8 | $150.5 | +19% |
ANF has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.